Skip to content

The effect of vitamin D on the treatment of gestational diabetes

Efficacy of vitamin D administration in preventing and controlling gestational diabetes and neonatal outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130311012782N34
Enrollment
100
Registered
2019-08-28
Start date
2018-03-21
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes. Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium

Interventions

Intervention 1: Intervention group: recipient of the 1000 IU vitamin D daily. Intervention 2: Intervention group: recipient of the 3000 IU vitamin D daily.

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: All mothers in the first trimester Having a risk factor for gestational diabetes (including a previous history of gestational diabetes, high body mass index, diabetes type 2 in the first degree family and a history of macrosomal infant birth) Having informed consent in a pregnant mother

Exclusion criteria

Exclusion criteria: Impaired glucose of mothers in the first trimester Evidence of overt diabetes

Design outcomes

Primary

MeasureTime frame
Vitamin D Level 3. Timepoint: baseline and 24-28 weeks of gestation. Method of measurement: Serum samples from patients using ELISA method.;Glucose tolerance test. Timepoint: baseline and 24-28 weeks and one time at 35-37 weeks of gestation. Method of measurement: Evaluation of blood glucose in patients at 0, 1, 2, 3 hours after consumption of 100 g glucose.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNooshin Amjadi

Shahid Beheshti University of Medical Sciences

nooshinamjadi@yahoo.com0098213323563

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026